Kobayashi Pharmaceutical has patented a method to prevent lidocaine reduction in pharmaceutical compositions. By using linear low-density polyethylene with a side chain carbon number of 4 or lower in the container, the quantity of lidocaine is maintained. GlobalData’s report on Kobayashi Pharmaceutical gives a 360-degree view of the company including its patenting strategy. Buy the report here.
According to GlobalData’s company profile on Kobayashi Pharmaceutical, Nanoemulsion cosmetics was a key innovation area identified from patents. Kobayashi Pharmaceutical's grant share as of January 2024 was 29%. Grant share is based on the ratio of number of grants to total number of patents.
A recently granted patent (Publication Number: US11833123B2) discloses a pharmaceutical composition containing lidocaine and/or its salt, housed in a container with an inner wall made of linear low-density polyethylene. The polyethylene used in the container has a side chain with a carbon number of 4 or less, ensuring the stability of the lidocaine within the composition. Additionally, the density of the linear low-density polyethylene falls within the range of 0.932 to 0.940 g/cm3, further contributing to the efficacy of the pharmaceutical composition.
Furthermore, the patented pharmaceutical composition can exist in the form of a liquid or a gel, providing versatility in its application. The method outlined in the patent aims to prevent the reduction in weight of lidocaine and/or its salt within the composition by utilizing the specific container material and structure. By placing the pharmaceutical composition in a container with the specified linear low-density polyethylene inner wall, which has a side chain with a carbon number of 4 or less, the method ensures the stability and integrity of the lidocaine component. This innovative approach not only safeguards the potency of the pharmaceutical composition but also enhances its shelf-life and effectiveness for medical use.
To know more about GlobalData’s detailed insights on Kobayashi Pharmaceutical, buy the report here.
See Also:
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.